EAM
Erste Asset Management Portfolio holdings
AUM
$11.9B
1-Year Return
22.95%
This Quarter Return
+22.83%
1 Year Return
+22.95%
3 Year Return
+112.82%
5 Year Return
+205.55%
10 Year Return
–
AUM
$3.61B
AUM Growth
+$682M
(+23%)
Cap. Flow
+$165M
Cap. Flow
% of AUM
4.58%
Top 10 Holdings %
Top 10 Hldgs %
17.47%
Holding
954
New
83
Increased
179
Reduced
131
Closed
34
Top Buys
| 1 |
Biogen
BIIB
|
+$35.3M |
| 2 |
Signet Jewelers
SIG
|
+$13.5M |
| 3 |
Microsoft
MSFT
|
+$12.7M |
| 4 |
Silicon Motion
SIMO
|
+$11M |
| 5 |
TJX Companies
TJX
|
+$11M |
Top Sells
| 1 |
Darden Restaurants
DRI
|
+$27.2M |
| 2 |
Tapestry
TPR
|
+$15.7M |
| 3 |
Ameriprise Financial
AMP
|
+$12.6M |
| 4 |
Abbott
ABT
|
+$9.4M |
| 5 |
Denali Therapeutics
DNLI
|
+$9.37M |
Sector Composition
| 1 | Technology | 27.61% |
| 2 | Healthcare | 21.59% |
| 3 | Consumer Discretionary | 15.04% |
| 4 | Industrials | 8.92% |
| 5 | Financials | 8.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
DCPH
326
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $1.01M | 0.03% |
18,300
| – | – |
|
327
Aflac
AFL
$56.9B
| $1M | 0.03% |
+22,900
| New | +$1M |
|
|
JNPR
328
DELISTED
Juniper Networks
JNPR
| $1M | 0.03% |
45,100
+13,200
| +41% | +$293K |
|
329
Relay Therapeutics
RLAY
$700M
| $980K | 0.03% |
+23,100
| New | +$980K |
|
330
Invesco
IVZ
$9.81B
| $973K | 0.03% |
+57,200
| New | +$973K |
|
331
Enbridge
ENB
$105B
| $972K | 0.03% |
30,400
+9,600
| +46% | +$307K |
|
332
Travere Therapeutics
TVTX
$1.89B
| $963K | 0.03% |
35,600
| – | – |
|
333
Intellia Therapeutics
NTLA
$1.28B
| $961K | 0.03% |
+17,600
| New | +$961K |
|
334
Vir Biotechnology
VIR
$721M
| $952K | 0.03% |
+33,300
| New | +$952K |
|
335
Axsome Therapeutics
AXSM
$6.45B
| $946K | 0.03% |
11,500
| – | – |
|
336
Lumen
LUMN
$5.78B
| $938K | 0.03% |
95,800
-190,200
| -67% | -$1.86M |
|
337
Rocket Pharmaceuticals
RCKT
$346M
| $933K | 0.03% |
+16,700
| New | +$933K |
|
338
Align Technology
ALGN
$9.85B
| $917K | 0.03% |
1,748
+422
| +32% | +$221K |
|
339
Prologis
PLD
$104B
| $908K | 0.03% |
9,284
-484
| -5% | -$47.3K |
|
340
Banco Bradesco
BBD
$33.3B
| $907K | 0.03% |
208,253
| – | – |
|
|
SWTX
341
DELISTED
SpringWorks Therapeutics
SWTX
| $894K | 0.02% |
+12,300
| New | +$894K |
|
342
Nektar Therapeutics
NKTR
$924M
| $854K | 0.02% |
3,120
-733
| -19% | -$201K |
|
343
Pacira BioSciences
PCRX
$1.2B
| $852K | 0.02% |
14,400
| – | – |
|
|
NSTG
344
DELISTED
NanoString Technologies, Inc.
NSTG
| $839K | 0.02% |
+12,900
| New | +$839K |
|
345
Veracyte
VCYT
$2.55B
| $833K | 0.02% |
+17,000
| New | +$833K |
|
346
PPG Industries
PPG
$25.2B
| $829K | 0.02% |
+5,800
| New | +$829K |
|
347
Arvinas
ARVN
$583M
| $822K | 0.02% |
+10,200
| New | +$822K |
|
348
ALX Oncology
ALXO
$59.4M
| $776K | 0.02% |
+9,200
| New | +$776K |
|
349
Grifois
GRFS
$6.88B
| $772K | 0.02% |
42,156
| – | – |
|
|
AMRN
350
Amarin Corp
AMRN
$306M
| $758K | 0.02% |
7,900
| – | – |
|